Related Experiment Video
Updated: May 20, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.2K
Advances in autonomic dysfunction research in Parkinson's disease
Hongjia Xu1, Xiaolei Zheng1, Xinyue Xing1
1Department of Neurology, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Frontiers in Aging Neuroscience
|March 27, 2025
Summary
This review explores autonomic dysfunction in Parkinson's disease (PD), highlighting its non-motor impact. Understanding these mechanisms may lead to new diagnostic and therapeutic approaches for PD patients.
Area of Science:
- Neuroscience
- Neurology
- Pathophysiology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder primarily recognized for motor symptoms like tremor and rigidity.
- Autonomic dysfunction is a significant non-motor feature of PD, causing substantial patient distress.
Purpose of the Study:
- To review recent advancements in understanding the pathophysiological mechanisms of autonomic dysfunction in PD.
- To explore the relationship between autonomic dysfunction and other clinical features of Parkinson's disease.
- To identify potential novel diagnostic and therapeutic strategies for autonomic dysfunction in PD.
Main Methods:
- Literature review of recent research on Parkinson's disease and autonomic dysfunction.
- Synthesis of pathophysiological mechanisms underlying autonomic dysfunction in PD.
- Analysis of the correlation between autonomic dysfunction and clinical manifestations of PD.
Main Results:
- Autonomic dysfunction is a critical non-motor symptom in Parkinson's disease.
- Understanding pathophysiological mechanisms is key to developing targeted treatments.
- Further research is needed to bridge basic science and clinical application.
Conclusions:
- Recent research offers insights into the complex mechanisms of autonomic dysfunction in PD.
- Developing novel diagnostic and therapeutic strategies is crucial for improving patient quality of life.
- This review aims to guide future clinical and basic research in Parkinson's disease management.
Related Concept Videos
Parkinson's Disease: Overview
399
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
399
Parkinson's Disease: Treatment
166
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
166
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Disorders of the Autonomic Nervous System
505
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
505
Alzheimer's Disease: Overview
399
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
399
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K

